Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 27, Issue 4, 2003, Pages 675-680

  Burbaeva, Gulnur Sh ^a   Boksha, Irina S ^a   Turishcheva, Marina S ^a   Vorobyeva, Elena A ^a   Savushkina, Olga K ^a   Tereshkina, Elena B ^a  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

Author keywords

Frontal cortex (area 10); Glutamate dehydrogenase isoenzymes; Glutamine synthetase; Glutamine synthetase like protein; Schizophrenia

Indexed keywords

BRAIN EXTRACT; GLUTAMATE AMMONIA LIGASE; GLUTAMATE DEHYDROGENASE; ISOENZYME; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLIA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; NERVE CELL; PREFRONTAL CORTEX; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; SCHIZOPHRENIA;

EID: 0038012557     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(03)00078-2     Document Type: Article

References (25)

1. Bartha R., Williamson P.C., Drost D.J., Malla A., Carr T.J., Cortese L., Canaran G., Rylett R.J., Neufeld R.W.J. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry. 54:1997;959-965.
2. Boksha I.S., Burbaeva G.Sh., Tereshkina E.B. Purification and some properties of glutamine synthetase from human brain. Biochemistry (Moscow). 60:1995;1299-1303.
3. Boksha I.S., Tereshkina E.B., Burbaeva G.Sh. Glutamine synthetase and glutamine synthetase-like protein from human brain: purification and comparative characterization. J. Neurochem. 75:2000;2574-2582.
4. Boksha I.S., Schönfeld H.-J., Langen H., Müller F., Tereshkina E.B., Burbaeva G.Sh. Glutamine synthetase isolated from human brain: octameric structure and homology of partial primary structure with human liver glutamine synthetase. Biochemistry (Moscow). 67:2002;1012-1020.
5. Buchsbaum M.S., Haier R.J., Potkin S.G., Nuechterlein K., Bracha H.S., Katz M., Lohr J., Wu J., Lottenberg S., Jerabek P.A. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch. Gen. Psychiatry. 49:1992;935-942.
6. Burbaeva G.Sh., Boksha I.S., Tereshkina E.B., Savushkina O.K. Biochemical approaches to the brain glutamate metabolism study in schizophrenia. Schizophr. Res. 36:1999;70.
7. Burbaeva G.Sh., Turishcheva M.S., Vorobyeva E.A., Savushkina O.K., Tereshkina E.B., Boksha I.S. Diversity of glutamate dehydrogenase in human brain. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 26:2002;427-435.
8. Davis J.M. Dose equivalence of the anti-psychotic drugs. J. Psychiatr. Res. 11:1974;65-69.
9. Dracheva S., Elhakem S.L., Davis K.L., Haroutunian V. GAD65 and GAD67 protein expression in dorsolateral prefrontal cortex of elderly schizophrenia patients. Biol. Psychiatry. 51:2002;166S.
10. Fukuzako H. Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. World J. Biol. Psychiatry. 2:2001;70-82.
11. Gluck M.R., Thomas R.G., Davis K.L., Haroutunian V. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am. J. Psychiatry. 159:2002;1165-1173.
12. Halberstadt A.L. The phencyclidine-glutamate model of schizophrenia. Clin. Neuropharmacol. 18:1995;237-249.
13. Hussain M.M., Zannis V.I., Plaitakis A. Characterization of GDH isoproteins purified from the cerebellum of normal subjects and patients with degenerative neurological disorders, and from human neoplastic cell lines. J. Biol. Chem. 264:1989;20730-20735.
14. Iqbal K., Ottaway J.H. Glutamine synthetase in muscle and kidney. Biochem. J. 119:1970;145-156.
15. Khelli M., Rolland B., Fages C., Tardy M. Glutamine synthetase modulation in astrocyte cultures of different mouse brain areas. Glia. 3:1990;75-80.
16. Krystal J.H., Belger A., D'Souza D.C., Anand A., Charney D.S., Aghajanian G.K., Moghaddam B. Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists. Neuropsychopharmacology. 21:1999;S143-S157.
17. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
18. McCullumsmith R.E., Haroutunian V., Davis K.L., Meador-Woodruff J.H. Expression of glutaminase transcripts in the thalamus of subjects with schizophrenia. Biol. Psychiatry. 51:2002;25S.
19. Ohnuma T., Augood S.J., Arai H., McCenna P.J., Emson P.C. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the frontal cortex from normal individuals and patients with schizophrenia. Mol. Brain Res. 56:1998;207-217.
20. Plaitakis A., Flessas P., Natsiou A.B., Shashidharan P. Glutamate dehydrogenase deficiency in cerebellar degenerations: clinical, biochemical and molecular genetic aspects. Can. J. Neurol. Sci. 3:1993;S109-S116. (Suppl.).
21. Robinson S.R. Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes. Neurochem. Int. 36:2000;471-482.
22. Tamminga C.A., Frost D.O. Changing concepts in the neurochemistry of schizophrenia. Am. J. Psychiatr. 158:2001;1365-1366.
23. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76:1979;4350-4354.
24. Tsai G., Passani L.A., Slusher B.S., Carter R., Baer L., Kleinman J.E., Coyle J.T. Abnormal excitatory neurotransmitter metabolism in schizophrenic brain. Arch. Gen. Psychiatry. 52:1995;829-836.
25. Uranova N., Orlovskaya D., Vikhreva O., Zimina I., Kolomeets N., Vostrikov V., Rachmanova V. Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull. 55:2001;597-610.